MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-17-0002482
Gripil Pharmaceuticals Private Limited - pharma in Vasai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5.12 Cr
▼ 30% YoY
Net profit · FY 2024
₹5.8 Lakh
Net margin 1.1%
EBITDA · FY 2024
₹32.66 Lakh
EBITDA margin 6.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹12 Lakh
Issued & subscribed
Open charges
₹21.85 Cr
Secured borrowings
Company age
17 yrs
Est. 2009
Employees · EPFO
11
Provident fund records
About Gripil Pharmaceuticals Private Limited
Data last updated:
Gripil Pharmaceuticals Private Limited is a private limited company based in Vasai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 July 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2009PTC194336. Its GSTIN is 27AADCG5111G1ZZ (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors Aarti Chandan Soni and Chandan Rajgopal Soni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vasai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.12 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹5.8 Lakh (net margin 1.1%) and EBITDA of ₹32.66 Lakh (EBITDA margin 6.4%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 10% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹21.85 Cr on record.
Gripil Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0002482). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gripil.com.
Company details
CIN U24100MH2009PTC194336
Registration Number 194336
Incorporation Date 23 July 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-17-0002482
Recognitions & Rankings of Gripil Pharmaceuticals
Contact details
Gripil Pharmaceuticals Private Limited's registered office is in Vasai, Maharashtra. Its website is gripil.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 2 Ground Flr Nagasai Apt., Chandansar Virar, Vasai, Maharashtra, India – 401303
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gripil Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Gripil Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Gripil Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gripil Pharmaceuticals Private Limited, buy the company report.
Financials of Gripil Pharmaceuticals Private Limited
FY 2025 filings availableGripil Pharmaceuticals Private Limited reported revenue of ₹5.12 Cr (down 30% YoY) for FY 2024.
Revenue · FY 2024
₹5.12 Cr ▼ 30%
Net profit · FY 2024
₹5.8 Lakh margin 1.1%
EBITDA · FY 2024
₹32.66 Lakh margin 6.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 17%
5 years · compounded
▼ 10%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 22%
5 years · compounded
▼ 30%
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 30% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gripil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gripil Pharmaceuticals Private Limited
Gripil Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aarti Chandan Soni Also directs: Gangaveda Private Limited | Director | 23 Jul 2009 | 17 Years 3 Months | Current |
| Chandan Rajgopal Soni | Director | 23 Jul 2009 | 17 Years 3 Months | Current |
Auditor
Gripil Pharmaceuticals Private Limited is audited by Aniket M Padhye & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Aniket M Padhye & Co. | FY 2023 | 118540W |
Shareholding
The shareholding of Gripil Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gripil Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹21.85 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2024 | 100911552 | Bank of India | ₹20 Cr | Open | |
| 01 Mar 2023 | 100694266 | Hdfc Bank Limited | ₹75 Lakh | Open | |
| 21 Oct 2015 | 10599466 | The Saraswat Co-Op Bank Ltd | ₹10 Lakh | Open | |
| 25 Feb 2010 | 10206359 | Others | ₹1 Cr | Open |
To see the full charge records of Gripil Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Gripil Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Gripil Pharmaceuticals Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 827 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Alicon Pharmaceutical Private Limited | |||
| an individual supplier | |||
| Mehta Associates | |||
| Sumit Laboratories | |||
| Collapsible Tube Corporation |
To see the full MSME payment records of Gripil Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Gripil Pharmaceuticals has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Gripil Pharmaceuticals Private Limited has a workforce of 11 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
Employee count
11
Active EPFO establishments
1
Employee growth
22.22%
GST
Gripil Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCG5111G1ZZ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gripil Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gripil Pharmaceuticals Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Jaswantrai Jagjivandas Mehta ceased to be Director on 01 Oct 2015.
AGM
Gripil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gripil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Bank Of India amounted to Rs. 2,000.00 Lakh with Charge ID 100911552 was registered on 26 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 75.00 Lakh with Charge ID 100694266 was registered on 01 Mar 2023.
Charges
A charge with Others of Rs. 100.00 Lakh registered on 25 Feb 2010 with Charge ID 10206359 was modified on 24 Jul 2020.
Charges
A charge with The Saraswat Co-Op Bank Ltd amounted to Rs. 10.00 Lakh with Charge ID 10599466 was registered on 21 Oct 2015.
Ceased
Jaswantrai Jagjivandas Mehta ceased to be Director.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 10206359 was registered on 25 Feb 2010.
Appointed
Aarti Chandan Soni was appointed as Director.
Appointed
Chandan Rajgopal Soni was appointed as Director.
Incorporation
23 Jul 2009
Gripil Pharmaceuticals Private Limited was registered on 23 Jul 2009 with Roc Mumbai & aged 17 years 3 months as per MCA records.
Frequently asked questions
Gripil Pharmaceuticals is an active private limited company based in Vasai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 July 2009 (17+ years old) and is registered under CIN U24100MH2009PTC194336.
Gripil Pharmaceuticals has 2 current directors:
- Aarti Chandan Soni - Director
- Chandan Rajgopal Soni - Director
The latest financial statements of Gripil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gripil Pharmaceuticals is 27AADCG5111G1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gripil Pharmaceuticals is U24100MH2009PTC194336. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gripil Pharmaceuticals was incorporated on 23 July 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Jaswantrai Jagjivandas Mehta ceased to be Director on 01 Oct 2015. Aarti Chandan Soni was appointed as Director on 23 Jul 2009. Chandan Rajgopal Soni was appointed as Director on 23 Jul 2009.
Yes, Gripil Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0002482).
Gripil Pharmaceuticals has 14 MSME Form 1 returns on record between 2019 and 2023, listing 827 overdue payments to 22 micro and small suppliers. The latest return was filed on 21 Oct 2023.
Gripil Pharmaceuticals can be reached through the website gripil.com. Its registered office is in Vasai, Maharashtra, India.
The registered office of Gripil Pharmaceuticals is at Flat No. 2 Ground Flr Nagasai Apt., Chandansar Virar, Vasai, Maharashtra, India – 401303.